92 related articles for article (PubMed ID: 20544708)
41. Fine-needle aspiration biopsy and flow cytometry immunophenotyping of lymphoid and myeloproliferative disorders of the spleen.
Zeppa P; Picardi M; Marino G; Troncone G; Fulciniti F; Vetrani A; Rotoli B; Palombini L
Cancer; 2003 Apr; 99(2):118-27. PubMed ID: 12704692
[TBL] [Abstract][Full Text] [Related]
42. Targeted use of fluorescence in situ hybridization (FISH) in cytospin preparations: results of 298 fine needle aspirates of B-cell non-Hodgkin lymphoma.
da Cunha Santos G; Ko HM; Geddie WR; Boerner SL; Lai SW; Have C; Kamel-Reid S; Bailey D
Cancer Cytopathol; 2010 Oct; 118(5):250-8. PubMed ID: 20862704
[TBL] [Abstract][Full Text] [Related]
43. Fluorescence in situ hybridization studies on direct smears: an approach to enhance the fine-needle aspiration biopsy diagnosis of B-cell non-Hodgkin lymphomas.
Monaco SE; Teot LA; Felgar RE; Surti U; Cai G
Cancer; 2009 Oct; 117(5):338-48. PubMed ID: 19711476
[TBL] [Abstract][Full Text] [Related]
44. The utilization of fine needle aspiration biopsy (FNAB) and flow cytometry (FC) in the diagnosis and classification of non-Hodgkin B-cell and T-cell lymphomas.
Swart GJ; Wright CA
Transfus Apher Sci; 2010 Apr; 42(2):199-207. PubMed ID: 20227345
[TBL] [Abstract][Full Text] [Related]
45. The diagnostic approach to fine-needle aspiration of malignant lymphoma: using cytomorphology and immunocytochemistry with cell transfer method.
Oh EJ; Hong SW; Jeong HJ; Yoon SO
Diagn Cytopathol; 2014 Aug; 42(8):671-9. PubMed ID: 24550126
[TBL] [Abstract][Full Text] [Related]
46. Correlation Between Digital and Manual Determinations of Ki-67/MIB-1 Proliferative Indices in Human Meningiomas.
Pham DT; Skaland I; Winther TL; Salvesen Ø; Torp SH
Int J Surg Pathol; 2020 May; 28(3):273-279. PubMed ID: 31771372
[No Abstract] [Full Text] [Related]
47. Growth fractions in canine non-Hodgkin's lymphomas as determined in situ by the expression of the Ki-67 antigen.
Fournel-Fleury C; Magnol JP; Chabanne L; Ghernati I; Marchal T; Bonnefond C; Bryon PA; Felman P
J Comp Pathol; 1997 Jul; 117(1):61-72. PubMed ID: 9263844
[TBL] [Abstract][Full Text] [Related]
48. MIB-1 Index as a Surrogate for Mitosis-Karyorrhexis Index in Neuroblastoma.
Atikankul T; Atikankul Y; Santisukwongchote S; Marrano P; Shuangshoti S; Thorner PS
Am J Surg Pathol; 2015 Aug; 39(8):1054-60. PubMed ID: 26171918
[TBL] [Abstract][Full Text] [Related]
49. [Comparison of proliferative activity in malignant lymphomas determined by immunohistologic methods with various antibodies].
Campr V; Benesová E; Kolárová M
Cesk Patol; 1997 May; 33(2):43-5. PubMed ID: 9340213
[TBL] [Abstract][Full Text] [Related]
50. Automated measurement of MIB-1 positive area as an alternative to counting in follicular lymphoma.
van der Laak JA; van Engelen N; Melissen M; Hebeda KM
Cytometry A; 2012 Jun; 81(6):527-31. PubMed ID: 22499389
[TBL] [Abstract][Full Text] [Related]
51. Grading follicular lymphoma on fine needle aspiration specimens. Comparison with proliferative index by DNA image analysis and Ki-67 labeling index.
Sun W; Caraway NP; Zhang HZ; Khanna A; Payne LG; Katz RL
Acta Cytol; 2004; 48(2):119-26. PubMed ID: 15085740
[TBL] [Abstract][Full Text] [Related]
52. FNA diagnosis of deep-seated lymphoma: an institutional experience.
Jin M; Wakely PE
J Am Soc Cytopathol; 2017; 6(3):114-119. PubMed ID: 31043261
[TBL] [Abstract][Full Text] [Related]
53. Telomerase activity in B-cell non-Hodgkin lymphoma.
Ely SA; Chadburn A; Dayton CM; Cesarman E; Knowles DM
Cancer; 2000 Jul; 89(2):445-52. PubMed ID: 10918178
[TBL] [Abstract][Full Text] [Related]
54. The utility of MIB-1/Ki-67 immunostaining in the evaluation of central nervous system neoplasms.
Prayson RA
Adv Anat Pathol; 2005 May; 12(3):144-8. PubMed ID: 15900115
[TBL] [Abstract][Full Text] [Related]
55. Flow-cytometry Assessment of DNA content and Immunophenotyping of Immune-cells in Lymph-node-specimens as a Potential Diagnostic Signature of Aggressiveness in B-Non-Hodgkin Lymphomas.
Azoulay D; Tapuchi T; Ronen O; Akria L; Cohen HI; Surio C; Chepa SR; Eshel E; Zarfati M; Stemer G; Horowitz NA
Ann Hematol; 2024 May; ():. PubMed ID: 38777843
[TBL] [Abstract][Full Text] [Related]
56. Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1. D. McCormick H. Chong, C. Hobbs, C. Datta & P. A. Hall. Histopathology 1993; 22; 355-360.
Cross SS
Histopathology; 2002 Sep; 41(3A):172. PubMed ID: 12405951
[No Abstract] [Full Text] [Related]
57. Multicolor flow cytometric assessment of Ki67 expression and its diagnostic value in mature B-cell neoplasms.
Mao X; Li Y; Liu S; He C; Yi S; Kuang D; Xiao M; Zhu L; Wang C
Front Oncol; 2023; 13():1108837. PubMed ID: 36890821
[TBL] [Abstract][Full Text] [Related]
58. Cytologic perspectives on neoteric B-cell lymphoproliferative disorders.
Sturgis CD; Monaco SE; Sakr H; Pantanowitz L
Diagn Cytopathol; 2017 Nov; 45(11):1005-1019. PubMed ID: 28594112
[TBL] [Abstract][Full Text] [Related]
59. Molecular classification of aggressive B-cell lymphoma.
Bojarczuk K; Chapuy B
Hemasphere; 2019 Jun; 3(Suppl):. PubMed ID: 35309802
[No Abstract] [Full Text] [Related]
60. MIB-1 labeling index as a prognostic factor for patients with follicular lymphoma treated with rituximab plus CHOP therapy.
Yamamoto E; Tomita N; Sakata S; Tsuyama N; Takeuchi K; Nakajima Y; Miyashita K; Tachibana T; Takasaki H; Tanaka M; Hashimoto C; Koharazawa H; Fujimaki K; Taguchi J; Harano H; Motomura S; Ishigatsubo Y
Cancer Sci; 2013 Dec; 104(12):1670-4. PubMed ID: 24112697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
